144 related articles for article (PubMed ID: 33126652)
1.
Decourcelle A; Very N; Djouina M; Loison I; Thévenet J; Body-Malapel M; Lelièvre E; Coqueret O; Leprince D; El Yazidi-Belkoura I; Dehennaut V
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126652
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
[TBL] [Abstract][Full Text] [Related]
3. Expression of unc5 family genes in zebrafish brain during embryonic development.
Yang B; Peng G; Gao J
Gene Expr Patterns; 2013 Dec; 13(8):311-8. PubMed ID: 23806443
[TBL] [Abstract][Full Text] [Related]
4. Augmented
Hirata Y; Nakagawa T; Moriwaki K; Koubayashi E; Kakimoto K; Takeuchi T; Inoue T; Higuchi K; Asahi M
J Clin Biochem Nutr; 2018 May; 62(3):221-229. PubMed ID: 29892160
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Polycomb Repression by
Decourcelle A; Leprince D; Dehennaut V
Front Endocrinol (Lausanne); 2019; 10():117. PubMed ID: 30873122
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer.
Yu M; Chu S; Fei B; Fang X; Liu Z
Exp Cell Res; 2019 Sep; 382(2):111464. PubMed ID: 31202709
[TBL] [Abstract][Full Text] [Related]
7. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment.
Thiebault K; Mazelin L; Pays L; Llambi F; Joly MO; Scoazec JY; Saurin JC; Romeo G; Mehlen P
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4173-8. PubMed ID: 12655055
[TBL] [Abstract][Full Text] [Related]
8. EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines.
Liu Y; Yu J; Xie Y; Li M; Wang F; Zhang J; Qi J
Exp Ther Med; 2020 Nov; 20(5):33. PubMed ID: 32952624
[TBL] [Abstract][Full Text] [Related]
9. OGT Controls the Expression and the Glycosylation of E-cadherin, and Affects Glycosphingolipid Structures in Human Colon Cell Lines.
Biwi J; Clarisse C; Biot C; Kozak RP; Madunic K; Mortuaire M; Wuhrer M; Spencer DIR; Schulz C; Guerardel Y; Lefebvre T; Vercoutter-Edouart AS
Proteomics; 2019 Nov; 19(21-22):e1800452. PubMed ID: 31373757
[TBL] [Abstract][Full Text] [Related]
10. Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis.
Miyamoto Y; Futamura M; Kitamura N; Nakamura Y; Baba H; Arakawa H
Int J Oncol; 2010 May; 36(5):1253-60. PubMed ID: 20372800
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
12. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
13. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.
Bernet A; Mazelin L; Coissieux MM; Gadot N; Ackerman SL; Scoazec JY; Mehlen P
Gastroenterology; 2007 Dec; 133(6):1840-8. PubMed ID: 17967459
[TBL] [Abstract][Full Text] [Related]
15. Potential coordination role between O-GlcNAcylation and epigenetics.
Wu D; Cai Y; Jin J
Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus.
Plissonnier ML; Lahlali T; Raab M; Michelet M; Romero-López C; Rivoire M; Strebhardt K; Durantel D; Levrero M; Mehlen P; Zoulim F; Parent R
Oncogene; 2017 Nov; 36(48):6712-6724. PubMed ID: 28783179
[TBL] [Abstract][Full Text] [Related]
17. Augmented TME
Moriwaki K; Asahi M
Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
[No Abstract] [Full Text] [Related]
18. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression of claudin 23 by the enhancer of zeste 2 polycomb group protein in colorectal cancer.
Maryan N; Statkiewicz M; Mikula M; Goryca K; Paziewska A; Strzałkowska A; Dabrowska M; Bujko M; Ostrowski J
Mol Med Rep; 2015 Jul; 12(1):728-36. PubMed ID: 25695204
[TBL] [Abstract][Full Text] [Related]
20. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
